A recent study demonstrates that partial PAD4 deficiency (PAD4+/− or DNase I treatment) reduces lung injury and improves survival in a murine model of bacterial pneumonia, while PAD4−/− mice show increased bacterial load and inflammation (76). This evidence concerns the gene PADI4 and bacterial pneumonia.